Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.

Case, D C

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. [electronic resource] - The American journal of medicine Dec 1977 - 897-903 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0002-9343

10.1016/0002-9343(77)90543-5 doi


Antineoplastic Agents--therapeutic use
Carmustine--therapeutic use
Cyclophosphamide--therapeutic use
Drug Therapy, Combination
Female
Humans
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Male
Melphalan--therapeutic use
Middle Aged
Multiple Myeloma--drug therapy
Prednisone--therapeutic use
Remission, Spontaneous
Time Factors
Vincristine--therapeutic use